ResMed Stock To Go Ex-dividend Tomorrow (RMD)

NEW YORK ( TheStreet) -- The ex-dividend date for ResMed (NYSE: RMD) is tomorrow, February 14, 2014. Owners of shares as of market close today will be eligible for a dividend of 25 cents per share. At a price of $45.94 as of 9:50 a.m. ET, the dividend yield is 2.2%.

The average volume for ResMed has been 1.2 million shares per day over the past 30 days. ResMed has a market cap of $6.45 billion and is part of the health care sector and health services industry. Shares are down 2.4% year to date as of the close of trading on Wednesday.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. You can view the full ResMed Ratings Report.

See our dividend calendar or top-yielding stocks list.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)

ResMed: Cramer's Top Takeaways

Why CarMax and Garmin Could Be Prime Candidates for a Short Squeeze

Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit

ResMed (RMD) Stock Sharply Lower After Q1 Results Miss Estimates